LALGFAOP Protocol for the treatment of childhood ALL
39,90 €
37,90 €
Économisez 5%
The present is an evaluation of the LALGFAOP protocol on 147 children distributed in Cameroon, Burkina Faso, Madagascar, Mali, Democratic Republic of Congo and Senegal.
This study shows that childhood ALL is present and in constant increase in these regions.
The age at initial diagnosis is 6.3±3.9 years with a mean at 5.
Complete remission is 79% at D33 of Induction.
Deaths at induction phase are at an acceptable level for this protocol of 7.48%.
Toxicities and complications during induction were: - Severe hemorrhagic Syndrome: 22/142; - Infectious Complications: 23/142 and Septicemia: 8/142.
After complete remission the high rate of death occurred among relapsed patients.
Disease Free Survival and overall survival were at 18 and 24 months: 62% CI= [50%; 73%] and 62% CI= [49%; 76%] respectively.
This protocol was well tolerated and constitutes a treatment basis of acute lymphoblastic leukemia.
A second step to be put in place will be the stratification phase based upon Immunophenotyping risks; together with cytogenetic that will make possible a risk stratification of patients and provide adequate treatment protocol.
Angèle Pondy is a Pediatrician Hemato-oncologist, Lecturer at the Faculty of Medicine and Biomedical Sciences (University of Yaounde I, Cameroon).
Since 2006, she’s the head of Hemato-Oncology Unit of Mother and Child Center of the Chantal Biya Foundation in Yaounde.
Holder of a Master on Advanced Oncology (Ulm University, Germany).
Fiche technique
- Auteur
- Angèle Hermine Pondy Ongotsoyi
- Langue
- Français
- Éditeur
- Éditions universitaires européennes
- Pages
- 64
- Pays
Cameroun
30 autres produits dans la même catégorie :
Voir tout
L’impact de COVID-19 sur la vie sexuelle de la femme enceinte
Amina Mnejja
43,90 €
-5%
41,70 €
- Nouveau
Les urgences infectieuses et post traumatiques en ophtalmologie
Fettouma Mazari
43,90 €
-5%
41,70 €
- Nouveau
Intérêt de l’étude immunologique dans le diagnostic des LGMD2
Ikhlass Belhassen
43,90 €
-5%
41,70 €
- Nouveau
Rôle de la poudre de feuilles du Moringa oleifera au Mali
Boubacar Sidiki Ibrahim DRAME
68,90 €
-5%
65,45 €
- Nouveau
Les Essais Cliniques de Phytothérapie pour la COVID-19 en Afrique
Jérôme MUNYANGI WA NKOLA
68,90 €
-5%
65,45 €
Fistules uro-génitales : expérience du service d’urologie de Monastir
Kamel Ktari
43,90 €
-5%
41,70 €
The present is an evaluation of the LALGFAOP protocol on 147 children distributed in Cameroon, Burkina Faso, Madagascar, Mali, Democratic Republic of Congo and Senegal.
This study shows that childhood ALL is present and in constant increase in these regions.
The age at initial diagnosis is 6.3±3.9 years with a mean at 5.
Complete remission is 79% at D33 of Induction.
Deaths at induction phase are at an acceptable level for this protocol of 7.48%.
Toxicities and complications during induction were: - Severe hemorrhagic Syndrome: 22/142; - Infectious Complications: 23/142 and Septicemia: 8/142.
After complete remission the high rate of death occurred among relapsed patients.
Disease Free Survival and overall survival were at 18 and 24 months: 62% CI= [50%; 73%] and 62% CI= [49%; 76%] respectively.
This protocol was well tolerated and constitutes a treatment basis of acute lymphoblastic leukemia.
A second step to be put in place will be the stratification phase based upon Immunophenotyping risks; together with cytogenetic that will make possible a risk stratification of patients and provide adequate treatment protocol.